GoodRx (GDRX) News Today $4.91 +0.01 (+0.20%) (As of 12/6/2024 05:53 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Pier Capital LLC Buys Shares of 469,547 GoodRx Holdings, Inc. (NASDAQ:GDRX)Pier Capital LLC purchased a new stake in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX - Free Report) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 469,547 shares of the company's stock, valued at approximately $3,259,000. Pier CapDecember 8 at 6:58 AM | marketbeat.comPoint72 Asset Management L.P. Makes New $11.30 Million Investment in GoodRx Holdings, Inc. (NASDAQ:GDRX)Point72 Asset Management L.P. bought a new position in GoodRx Holdings, Inc. (NASDAQ:GDRX - Free Report) in the third quarter, according to its most recent disclosure with the SEC. The firm bought 1,627,590 shares of the company's stock, valued at approximately $11,295,000. Point72 Asset ManagementDecember 8 at 4:32 AM | marketbeat.comGoodRx Holdings (NASDAQ:GDRX) Stock Quotes, Forecast and News SummaryDecember 6 at 3:03 AM | benzinga.comWegovy and Zepbound are leading this year's weight loss drug prescription surgeDecember 5 at 10:01 PM | msn.comGoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still SurgedDecember 5 at 10:01 PM | finance.yahoo.comPrescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx saysDecember 5 at 9:00 AM | cnbc.comMizuho Begins Coverage on GoodRx (NASDAQ:GDRX)December 5 at 4:03 AM | americanbankingnews.comGoodRx initiated with a Neutral at MizuhoDecember 4, 2024 | markets.businessinsider.comNationwide PBM litigation could land in Rhode IslandDecember 2, 2024 | bizjournals.comShort Interest in GoodRx Holdings, Inc. (NASDAQ:GDRX) Declines By 13.9%December 1, 2024 | americanbankingnews.comShort Interest in GoodRx Holdings, Inc. (NASDAQ:GDRX) Drops By 13.9%GoodRx Holdings, Inc. (NASDAQ:GDRX - Get Free Report) was the target of a large decrease in short interest during the month of November. As of November 15th, there was short interest totalling 7,480,000 shares, a decrease of 13.9% from the October 31st total of 8,690,000 shares. Based on an average trading volume of 1,370,000 shares, the days-to-cover ratio is currently 5.5 days. Approximately 8.7% of the company's stock are sold short.December 1, 2024 | marketbeat.comGoodRx Holdings, Inc. (NASDAQ:GDRX) Receives $8.86 Average Price Target from BrokeragesNovember 30, 2024 | americanbankingnews.comGoodRx (NASDAQ:GDRX) Shares Gap Up - Time to Buy?GoodRx (NASDAQ:GDRX) Shares Gap Up - What's Next?November 29, 2024 | marketbeat.comRubric Capital Management LP Has $32.48 Million Holdings in GoodRx Holdings, Inc. (NASDAQ:GDRX)Rubric Capital Management LP increased its holdings in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX - Free Report) by 25.2% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,680,028 shares of the company's stock after purchasinNovember 27, 2024 | marketbeat.comGoodRx Holdings, Inc. (NASDAQ:GDRX) Given Average Rating of "Moderate Buy" by BrokeragesGoodRx Holdings, Inc. (NASDAQ:GDRX - Get Free Report) has received a consensus rating of "Moderate Buy" from the fifteen research firms that are presently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, four have assigned a holdNovember 27, 2024 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Reduces Holdings in GoodRx Holdings, Inc. (NASDAQ:GDRX)Connor Clark & Lunn Investment Management Ltd. lowered its position in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX - Free Report) by 14.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 886,055 shares of the company's stoNovember 23, 2024 | marketbeat.comGoodRx (NASDAQ:GDRX) Trading Up 8.2% - Time to Buy?GoodRx (NASDAQ:GDRX) Trading Up 8.2% - What's Next?November 22, 2024 | marketbeat.comGoodRx Holdings: Undervalued Stock with Strong EBITDA Growth and Positive OutlookNovember 21, 2024 | markets.businessinsider.comGoodRx (NASDAQ:GDRX) Sees Strong Trading Volume - Here's WhyGoodRx (NASDAQ:GDRX) Sees Large Volume Increase - Here's What HappenedNovember 18, 2024 | marketbeat.comGoodRx (NASDAQ:GDRX) Trading Down 7.5% - Here's What HappenedGoodRx (NASDAQ:GDRX) Stock Price Down 7.5% - What's Next?November 15, 2024 | marketbeat.comKuehn Law Encourages Investors of GoodRx Holdings, Inc. to Contact Law FirmNovember 13, 2024 | prnewswire.comGOODRX ALERT: Bragar Eagel & Squire, P.C. is Investigating GoodRx Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmNovember 12, 2024 | globenewswire.comGoodRx price target lowered to $6 from $10 at BarclaysNovember 12, 2024 | markets.businessinsider.comGoodRx Holdings (GDRX) Receives a Hold from Truist FinancialNovember 12, 2024 | markets.businessinsider.comBarclays Cuts GoodRx (NASDAQ:GDRX) Price Target to $6.00Barclays reduced their target price on shares of GoodRx from $10.00 to $6.00 and set an "overweight" rating on the stock in a research note on Monday.November 11, 2024 | marketbeat.comGoodRx Holdings: Mixed Signals Prompt Hold Rating Amid Revenue Challenges and EBITDA ProspectsNovember 9, 2024 | markets.businessinsider.comGoodRx Holdings: Strategic Shift Towards Branded Medications Amid Uncertain 2025 OutlookNovember 9, 2024 | markets.businessinsider.comGoodRx Holdings Inc (GDRX) Q3 2024 Earnings Call Highlights: Strong Financial Performance ...November 9, 2024 | finance.yahoo.comGoodRx price target lowered to $8 from $9 at Deutsche BankNovember 9, 2024 | markets.businessinsider.comGoodRx Holdings (GDRX) Gets a Buy from BarclaysNovember 9, 2024 | markets.businessinsider.comWhy GoodRx Holdings Stock Was Sinking This WeekNovember 8, 2024 | fool.comGoodRx sees Q4 revenue ~$200M, consensus $206.25MNovember 8, 2024 | markets.businessinsider.comGoodRx reports Q3 adjusted EPS 8c, consensus 9cNovember 8, 2024 | markets.businessinsider.comGoodRx (GDRX) Q3 2024 Earnings Call TranscriptNovember 8, 2024 | finance.yahoo.comGoodRx Holdings, Inc. (GDRX) Q3 2024 Earnings Call TranscriptNovember 7, 2024 | seekingalpha.comGoodRx (NASDAQ:GDRX) Shares Down 13.9% - Here's What HappenedGoodRx (NASDAQ:GDRX) Shares Down 13.9% - What's Next?November 7, 2024 | marketbeat.comGoodRx Holdings Inc (GDRX) Q3 2024 Earnings Report Preview: What to ExpectNovember 6, 2024 | finance.yahoo.comGoodRx accused of conspiring with PBMs over reimbursement feesNovember 6, 2024 | msn.comGoodRx and CVS Sued for Suppressing Pharmacy ReimbursementNovember 5, 2024 | pymnts.comRaymond James & Associates Boosts Stock Holdings in GoodRx Holdings, Inc. (NASDAQ:GDRX)Raymond James & Associates boosted its position in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX - Free Report) by 212.6% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 394,006 shares of the company's stock after buying an addiNovember 5, 2024 | marketbeat.comGoodRx to Participate in Upcoming Investor ConferencesNovember 4, 2024 | businesswire.comGoodRx Holdings, Inc. (NASDAQ:GDRX) Given Consensus Rating of "Moderate Buy" by BrokeragesGoodRx Holdings, Inc. (NASDAQ:GDRX - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the fifteen analysts that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, four have issued a hold recommendatNovember 2, 2024 | marketbeat.comKuehn Law Encourages Investors of GoodRx Holdings, Inc. to Contact Law FirmOctober 31, 2024 | globenewswire.comGoodRx Unveils New E-commerce Platform, Launches with Opill®October 31, 2024 | finance.yahoo.comCautious Outlook and Sell Rating for GoodRx Holdings Amid Limited Market Potential and Overvaluation ConcernsOctober 31, 2024 | markets.businessinsider.comAssenagon Asset Management S.A. Sells 639,205 Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX)Assenagon Asset Management S.A. reduced its position in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX - Free Report) by 62.4% in the third quarter, according to its most recent filing with the SEC. The fund owned 385,420 shares of the company's stock after selling 639,205 shares during the quarter.October 31, 2024 | marketbeat.comGoodRx (GDRX) Set to Announce Earnings on ThursdayGoodRx (NASDAQ:GDRX) will be releasing earnings before the market opens on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=608008)October 31, 2024 | marketbeat.comGoodRx stock moves on exclusive 30-day offer of weight management drug QsymiaOctober 30, 2024 | uk.finance.yahoo.comGoodRx announces exclusive cash price for QsymiaOctober 29, 2024 | markets.businessinsider.comGoodRx Holdings Strengthens Board with New AppointmentOctober 29, 2024 | markets.businessinsider.com Get GoodRx News Delivered to You Automatically Sign up to receive the latest news and ratings for GDRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Financial Prophecy (Ad)The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier. Including the name of the #1 company to buy. GDRX Media Mentions By Week GDRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GDRX News Sentiment▼0.290.69▲Average Medical News Sentiment GDRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GDRX Articles This Week▼107▲GDRX Articles Average Week Get GoodRx News Delivered to You Automatically Sign up to receive the latest news and ratings for GDRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Lyft News Today QXO News Today Etsy News Today Nuvei News Today TriNet Group News Today Alight News Today Clarivate News Today DXC Technology News Today CarGurus News Today Life360 News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GDRX) was last updated on 12/8/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredUrgent warning about your moneyThe stock market is booming … And Bitcoin just hiked through the roof. But don't get fooled by the "good...Weiss Ratings | SponsoredElon declares war on company he co-founded!?Elon Musk is leading humanity into the new era of AI. He’s just received a fresh $6 billion in funding for ...Porter & Company | SponsoredWall Street genius says this bubble has run its course – what to doWhile the media is telling you to be excited about the stock market, Wall Street and the market's top experts ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GoodRx Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GoodRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GDRX Stock Alerts